CERT

Certara (CERT)

About Certara (CERT)

Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.

Details

Daily high
$9.16
Daily low
$8.93
Price at open
$8.93
52 Week High
$15.69
52 Week Low
$8.02
Market cap
1.4B
Dividend yield
0.00%
Volume
3.9M
Avg. volume
2.4M
P/E ratio
134.57

Certara News

Details

Daily high
$9.16
Daily low
$8.93
Price at open
$8.93
52 Week High
$15.69
52 Week Low
$8.02
Market cap
1.4B
Dividend yield
0.00%
Volume
3.9M
Avg. volume
2.4M
P/E ratio
134.57